Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2026 ,inter alia, to consider and approve 1) Approval of unaudited standalone and consolidated financial results of the Company for the quarter and half year ended September 30, 2026 2) Approval for voluntary full redemption of 20,000 Listed NCDs of face value of Rs. 1,00,000 each.

October 28, 2026 BSE Limited National Stock Exchange of India Limited Department of Corporate Services, Listing Department, Exchange Plaza, Floor 25, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai 400 001 Mumbai – 400 051 Scrip Code No: 542665 Company Symbol: NEOGEN Debt Segment Code: 977028 Sub: Intimation of Board Meeting pursuant to regulation 29 and 50 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 (” Listing Regulations”). Dear Sir/Madam, Pursuant to regulation 29, 33, 50 and other applicable regulations of the Listing Regulations, notice is hereby given that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday, October 31, 2026, inter-alia: a) To consider, approve and take on record the un-audited standalone and consolidated financial results of the Company for the quarter and half year ended on September 30, 2026. b) To consider, evaluate and approve the proposal for voluntary redemption (in full) of 20,000 (Twenty thousand) fully paid, secured, listed, rated, redeemable, rupee denominated, non-cumulative, non-convertible debentures having a face value of Rs. 1,00,000 each aggregating to INR 200,00,00,000 (Indian Rupees Two Hundred Crores only) (“NCDs”), issued and allotted by the Company on private placement basis on August 12, 2025, bearing ISIN INE136S07013, on such terms and conditions as may be deemed appropriate by the Board in its absolute discretion in accordance with the terms of General Information Document dated July 28, 2025 read with Key Information Document dated August 11, 2025 (“Disclosure Document”), the Debenture Trust Deed, and subject to receipt of such other necessary approvals including regulatory / statutory approvals as may be required. Further, we wish to inform that pursuant to our intimation dated September 25, 2026, the trading window for dealing in the securities of the Company shall remain closed for all designated persons and their immediate relatives, connected persons and legitimate insiders of the Company from October 1, 2026 till the end of 48 hours after the declaration of Un-Audited (standalone and consolidated) financial results of the Company for the quarter and half year ended September 30, 2026, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015. This intimation is also being uploaded on the Company’s website at https://neogenchem.com/financial- performance/ and at https://neogenchem.com/announcements/ under the tab > Issue of Securities. The same may please be taken on record. Thanking you, For Neogen Chemicals Limited Unnati Kanani Company Secretary & Compliance Officer Mem. No: A35131 Registered Office: 1002, Dev Corpora, Cadbury Junction, E: sales@neogenchem.com T: +91 22 2549 7300 Eastern Express Highway, Thane (W) 400 601, India. W: www.neogenchem.com F: +91 22 2549 7399 CIN No. L24200MH1989PLC050919